Spire Healthcare Group (LON:SPI) Shares Up 14.1% - Should You Buy?

Key Points

• Spire Healthcare Group shares increased by 14.1%, reaching a last trading price of GBX 247 ($3.35), with trading volume significantly up at 9,747,062 shares.
• Analysts maintain a generally positive outlook, with a majority rating the stock as a "Buy" and a consensus price target of GBX 294.33.
• For the current year, Spire Healthcare Group is expected to report earnings per share (EPS) of approximately 15.66, following a recent quarterly EPS of GBX 4.10.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 14.1% during mid-day trading on Friday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). 9,747,062 shares changed hands during mid-day trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Wall Street Analysts Forecast Growth

Several research firms have issued reports on SPI. JPMorgan Chase & Co. decreased their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research note on Tuesday, August 5th. Berenberg Bank reissued a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a research note on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of GBX 294.33.

Spire Healthcare Group Price Performance

The firm has a market cap of £981.79 million, a price-to-earnings ratio of 5,304.35, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The stock's fifty day moving average price is GBX 218.75 and its 200-day moving average price is GBX 203.55.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Equities research analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.